Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Dieses Wertpapier wird aktuell nicht bei uns gehandelt
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Roche Holding AG ADR

WKN: 891106 / Symbol: RHHBY / Name: Roche / Aktie / Pharmazeutika / Large Cap /

49,77 €
0,70 %

Roche Bobois S.a.

WKN: A2JQRU / Name: Roche Bobois S.a. / Aktie / ? /

?
-0,94 %

Roche Holding AG

WKN: A4124Y / Name: Roche Holding / Aktie / ? /

?
-2,20 %

Roche Holding AG

WKN: A40CGQ / Name: Roche Holding / Aktie / ? /

?
-0,59 %

Roche Finance Europe B.v.

WKN: A3LEL7 / Name: Roche Finance Europe B.v. / Aktie / ? /

100,48 €
-0,06 %

Roche Finance Europe B.v.

WKN: A3LEL8 / Name: Roche Finance Europe B.v. / Aktie / ? /

98,92 €
-

Roche Finance Europe B.v.

WKN: A3LRTS / Name: Roche Finance Europe B.v. / Aktie / ? /

100,51 €
0,06 %

Roche Finance Europe B.v.

WKN: A3LRTT / Name: Roche Finance Europe B.v. / Aktie / ? /

99,09 €
-

Roche Finance Europe B.v.

WKN: A3LX6K / Name: Roche Finance Europe B.v. / Aktie / ? /

100,41 €
0,10 %

Roche Finance Europe B.v.

WKN: A3LX6L / Name: Roche Finance Europe B.v. / Aktie / ? /

93,60 €
-0,60 %

Roche Holdings Inc.

WKN: A3LVX8 / Name: Roche Holdings Inc. / Aktie / ? /

91,70 €
-

Roche Holding AG

WKN: A424UK / Name: Roche Holding / Aktie / ? /

386,50 €
-1,63 %

Roche Holding AG

WKN: 851311 / Name: Roche / Aktie / Pharmazeutika / Micro Cap /

392,80 €
-1,16 %

Recursion Pharmaceuticals Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Recursion Pharmaceuticals Q2 Earnings Call Highlights

Key Points

Roche Aktie: Kooperation mit ChemoMetec abgeschlossenPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Roche Aktie: Kooperation mit ChemoMetec abgeschlossen

Roche stellt die Weichen für ein wachstumsstarkes zweites Halbjahr. Der Schweizer Gesundheitskonzern kombiniert operative…

Der Beitrag Roche Aktie: Kooperation mit ChemoMetec abgeschlossen erschien

Rochefocauld
Account aktiviert

The Hanover Insurance Group Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
The Hanover Insurance Group Q2 Earnings Call Highlights

The Hanover Insurance Group (NYSE:THG) reported record second-quarter operating performance, citing improved underwriting margins, accelerating premium growth and higher investment income across

Alnylam Pharmaceuticals Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Alnylam Pharmaceuticals Q2 Earnings Call Highlights

Key Points

Madrigal Pharmaceuticals Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Madrigal Pharmaceuticals Q2 Earnings Call Highlights

Key Points

OraSure Technologies Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
OraSure Technologies Q2 Earnings Call Highlights

Key Points